Industry News II

Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities – Press Releases

September 19, 2012 No Comments »

NEW YORK, Sept. 19, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities

http://www.reportlinker.com/p0970178/Transdermal-Pain-Management-to-2016-Products-Markets-Forecasts-and-Opportunities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Currently approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics. These patches and gels will encounter competition from development-stage transdermal formulations for a number of pain medications presently being marketed in oral or parenteral form. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

Highlights

• Analyzes and evaluates the global market opportunity for transdermal pain management and assesses the probable impact of evolving regulatory, economic and demand factors

• Assesses transdermal products approved or in development for the delivery of therapeutic pain management drugs

• Provides detailed descriptions of pain management treatment segments, market factors, and business strategies

• Forecasts transdermal pain management product demand to 2016 by geographic region and product segment

• Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

Executive Summary

Scope and Definitions

The Current Pain Management Picture

Unmet Needs in Pain Management

The Opportunity for Transdermal Delivery of Pain Drugs

The Pain Management Market Opportunity

Evolution in Pain Management Guidelines

Regional Factors in Pain Management Practice

Pain Management Demand Drivers

Competitive Landscape

Factors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal Pain Management Patches

Pain Patch Technology & Architectures

Transdermal Patch Manufacturing and Packaging

Patch Economics

Passive vs Active Delivery Systems

Transdermal Pain Management Gels

Transdermal Formulations

IP and Proprietary Technology

Limitations of Topical Gels

Transdermal Pain Management Product Assessments and Market Prospects

FDA Approved Transdermal Pain Management Products

Narcotic

NSAIDs

Local Anesthetic

Non-FDA Approved Commercial Transdermal Pain Management Products

Narcotic

NSAIDs

Local Anesthetic

Development-Stage Transdermal Pain Management Products

Narcotic

NSAID

Other Drug Classes

Transdermal Pain Management Market Factors

Regional Regulations

Clinical Trials

Quality and Reliability

Indications Prescribing Guidelines and Off-Label Prescribing

Managed Care and Payor Initiatives

Rx-to-OTC Switching

Skin Patch Revenue Models

Market Forecasts

Forecasts by Region

Forecasts by Drug Class

Forecasts by Delivery Form Factor

Market Share Data

Market Participant Profiles

To order this report:Drug_and_Medication Industry: Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities

Contact
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Powered by WPeMatico

Leave A Response